DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Loupakis F. et al.
FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer.

Eur J Cancer 2014;
50: 57-63

Download Bibliographical Data

Access: